Microbiota–Gastric Cancer Interactions and the Potential Influence of Nutritional Therapies

Pauline Raoul,Valeria Maccauro,Marco Cintoni,Emidio Scarpellini,Gianluca Ianiro,Antonio Gasbarrini,Maria Cristina Mele,Emanuele Rinninella
DOI: https://doi.org/10.3390/ijms25031679
IF: 5.6
2024-01-31
International Journal of Molecular Sciences
Abstract:Gastric cancer (GC) is one of the most common causes of cancer deaths, and GC treatments represent a large area of research. Although initially regarded as a sterile organ and unsuitable for microbial communities, the discovery of Helicobacter pylori made us realize that some microbes can colonize the stomach. In recent years, growing interest in gastric bacteria has expanded to the gut microbiota and, more recently, to the oral microbiota. Indeed, the oral–gastric–gut microbiota axis may play a crucial role in maintaining homeostasis, while changes in microbiota composition in GC patients can influence clinical outcomes. On the one hand, the microbiota and its metabolites may significantly influence the progression of GC, while anti-GC treatments such as gastrectomy and chemotherapy may significantly impact the oral–gastric–gut microbiota axis of GC patients. In this context, the role of nutritional therapies, including diet, prebiotics, and probiotics, in treating GC should not be underestimated. Wit this review, we aim to highlight the main role of the gastric, oral, and gut microbiota in GC onset and progression, representing potential future biomarkers for early GC detection and a target for efficient nutritional therapies during the course of GC.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to explore the interaction between the gastric microbiota and gastric cancer, and to evaluate the potential impact of nutritional therapy in the treatment of gastric cancer. Specifically, the research focuses on the following points: 1. **Relationship between gastric microbiota and gastric cancer**: The paper explores how the gastric microbiota affects the occurrence and development of gastric cancer. The study points out that although the gastric environment was once considered unsuitable for microbial survival, with the discovery of Helicobacter pylori (*Helicobacter pylori*), people have realized that certain microorganisms can colonize the stomach. In recent years, the interest in gastric bacteria has extended to the gut microbiota, and more recently to the oral microbiota. Changes in these microbiota may affect clinical outcomes in patients with gastric cancer. 2. **Effect of microbiota metabolites on gastric cancer**: The paper discusses how the microbiota and its metabolites significantly affect the progression of gastric cancer. For example, Helicobacter pylori promotes the development of gastric cancer by affecting cell junctions and autophagy through its oncogenic proteins CagA and VacA. 3. **Effect of treatment on microbiota**: Treatment methods for gastric cancer, such as gastrectomy and chemotherapy, may significantly affect the oral - gastric - intestinal microbiota axis of patients. Therefore, understanding these changes is of great significance for optimizing treatment regimens. 4. **Role of nutritional therapy**: The paper emphasizes the potential value of nutritional therapy (including diet, prebiotics, and probiotics) in the treatment of gastric cancer. These therapies can not only improve the nutritional status of patients, but also improve treatment compliance and quality of life. In summary, this paper aims to comprehensively overview the main roles of the gastric, oral, and intestinal microbiota in the occurrence and development of gastric cancer, provide potential biomarkers for early gastric cancer detection, and explore the application of effective nutritional therapies in the treatment of gastric cancer.